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The yeast protein Rbl2p suppresses the deleterious effects of excess b-tubulin as efficiently as does a-tubulin.
Both in vivo and in vitro, Rbl2p forms a complex with b-tubulin that does not contain a-tubulin, thus defining
a second pool of b-tubulin in the cell. Formation of the complex depends upon the conformation of b-tubulin.
Newly synthesized b-tubulin can bind to Rbl2p before it binds to a-tubulin. Rbl2p can also bind b-tubulin from
the a/b-tubulin heterodimer, apparently by competing with a-tubulin. The Rbl2p–b-tubulin complex has a
half-life of ;2.5 h and is less stable than the a/b-tubulin heterodimer. The results of our experiments explain
both how excess Rbl2p can rescue cells overexpressing b-tubulin and how it can be deleterious in a wild-type
background. They also suggest that the Rbl2p–b-tubulin complex is part of a cellular mechanism for regulating
the levels and dimerization of tubulin chains.
Much of the work on microtubules has focused on the as-
sembly reaction from a/b-tubulin heterodimer to polymer.
This reaction is well characterized in vitro, and genetic and
pharmacological studies demonstrate its importance and pos-
sible in vivo mechanisms for its regulation. Less well under-
stood are the steps leading to the formation of the heterodimer
in the cell. There is now considerable evidence that these steps
are themselves subject to cellular controls crucial for microtu-
bule function.
The proper folding of the tubulin chains in vivo (22, 23) and
in vitro (6, 12, 26) apparently requires the action of chaperone
complexes (variously abbreviated as TriC/CCT/TCP/c-cpn).
Unlike other proteins that are TriC substrates, however, a- and
b-tubulin require other proteins in vitro to exchange into ex-
ogenous heterodimers, as assayed by native gel electrophoresis
(2, 7, 8). The extent to which this in vitro reaction is applicable
to the in vivo situation is unknown, beginning as it does with
fully denatured protein rather than newly synthesized protein
(5). Comparison of elements of the in vitro reaction with cel-
lular activities reveals both similarities and differences. For
example, yeast strains with altered forms of TCP-1 genes do
exhibit cytoskeleton defects (3, 15, 22–24). On the other hand,
a protein that is required for the in vitro reaction is the ho-
molog of a yeast protein, Cin1p, that is not essential in vivo but
which may be involved in microtubule functions (10, 20, 21).
A recent study of the in vitro folding reaction identified
cofactor A, which promotes the recovery of b-tubulin, as a
monomer from the chaperonin (7). However, in this assay, the
form of b-tubulin released by cofactor A does not exchange
into exogenous dimer. A genetic analysis of cellular responses
to b-tubulin levels identified Rbl2p as a yeast structural ho-
molog of cofactor A; Rbl2p is a nonessential protein that
suppresses the lethality associated with overexpression of b-tu-
bulin (1). The murine cofactor A was shown to partially replace
Rbl2p in this in vivo assay (1). Although results of the in vitro
assay first suggested that cofactor A was a co-chaperonin, the
yeast experiments demonstrated that Rbl2p interacts with
b-tubulin directly, rather than with TCP-1. Results of a revised
version of the in vitro assay agree with the observation that
Rbl2p/cofactor A interacts with b-tubulin rather than with
TriC and that Rbl2p is not essential for b-tubulin folding (21).
More recently, Melki and colleagues (14) have shown that
cofactor A, like Rbl2p, binds noncovalently to b-tubulin. This
cofactor A–b-tubulin complex elutes from a gel filtration col-
umn in a position consistent with it being a 1:1 heterodimer.
To analyze the function of Rbl2p in the cell, we have isolated
and characterized a stable complex of Rbl2p and b-tubulin,
formed both in vivo and in vitro, that lacks a-tubulin. The data
suggest that Rbl2p binds to a folded form of b-tubulin and
predict possible roles for Rbl2p in the regulation of tubulin
assembly.
MATERIALS AND METHODS
Plasmids, strains, and media. pQE-60/RBL2 was used to produce recombi-
nant His6-Rbl2p in Escherichia coli. This plasmid was constructed by PCR to add
NcoI and BglII sites to the RBL2 gene just before the start codon and just after
the penultimate codon, respectively. The PCR primers were 59TAGGACACC
ATGGCACCCACACAATTG39 and 59AATCTGAGATCTTTTAGAATCGA
GTAATTC39. The PCR product was cloned into the NcoI and BglII sites of
Qiagen vector pQE-60.
pGRH allows inducible expression of His6-Rbl2p in Saccharomyces cerevisiae.
pQE-60/RBL2 was digested with HindIII, blunted, and then digested with MfeI.
This fragment was cloned into pA5 (URA3 CEN GAL1-10 promoter [1]) that had
been digested with NotI, blunted, and then digested with MfeI. pMM11 is a 2-mm
plasmid encoding His6-Tub2p under control of the GAL1-10 promoter. Starting
with the vector pBW47 containing the 39 half of TUB2 (25), we used PCR to
generate a fragment containing an NcoI site 59 of codon 291 and a BglII site just
after the penultimate codon. The 59 primer was 59CCGGACACCATGGCAGC
AAATGTTTGAT39. The 39 primer was 59CAATCTTAGATCTTTCAAAATT
CTCAGTGAT39. This fragment was cloned into the NcoI and BglII sites of
pQE-60, placing six histidine codons at the carboxy terminus followed by a stop
codon. A SalI-HindIII fragment was cut from this construct and cloned into
pBW54 (25) from which the SalI-SacI fragment had been removed.
All yeast strains used in this study are derivatives of FSY182, -183, or -185 (25).
JAY47 is a diploid containing a third copy of the TUB2 gene integrated at the
TUB2 locus and under control of the GAL promoter (1). JAY614 is FSY185 plus
pGRH. JAY570 is JAY47 plus pGRH. FSY820 is a derivative of FSY182 con-
taining a deletion of the chromosomal RBL2 locus (1). This strain was trans-
formed with a CEN plasmid (marked with URA3) bearing tub2-590 under control
of the GAL promoter (25) and with a CEN plasmid (HIS3) encoding His6-Rbl2p
under control of the RBL2 promoter. The latter plasmid was created by cutting
pGRH with MfeI and PvuII and subcloning the fragment into pJA33, a plasmid
containing the entire RBL2 gene (1) from which the MfeI-EcoRV fragment had
been removed. FSY821 is similar to FSY820 except that it constitutively ex-
presses tub2-590 and contains TUB2 under control of the GAL promoter. We
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crossed FSY127 (tub2-590 [11]) with FSY 611 (rbl2::URA3-hisG). We identified
sporulated segregants bearing the marker for the Drbl2 allele (by the URA3 gene)
and the tub2-590 allele by Western blotting. These segregants were plated on
5-fluoro-orotic acid, and cells that had looped out the URA3 sequence were
recovered. Finally, these cells were transformed with plasmids pBW54, contain-
ing GAL-TUB2 (25), and pJA33, a CEN plasmid encoding His6-Rbl2p under
control of the RBL2 promoter. LTY333 contains the pMM11 plasmid in FSY182
(Dtub1 Dtub3 PRB539) (16). LTY292 is FSY182 plus pGRH (16).
We used standard methods and media (18, 19).
Purification of His6-tagged proteins. The Ni-nitrilotriacetic acid (NTA) slurry
and column materials were from Qiagen. We used protocols that are slight
modifications of both those described earlier (13) and those recommended by the
manufacturer. Immunoblot signals were quantified from multiple burns within
the linear range by using the IS-1000 Digital Imaging System (Alpha Innotech
Corporation).
In vivo association experiments. We grew LTY292 overnight in selective
raffinose medium and then induced expression with galactose for 10 to 16 h. We
harvested protein by glass bead smash (19), using approximately 4 3 109 cells per
experiment. We used a volume of PME buffer plus protease inhibitors (19) equal
to the volume of the cell pellet. After centrifugation (13,000 3 g, 30 min), 850 ml
of extract was mixed with 130 ml of Ni-NTA slurry that had been preincubated
with buffer I (20 mM imidazole, 300 mM NaCl, 50 mM sodium phosphate buffer
[pH 8.0]). After a 1-h incubation at 4°C, we washed the Ni-NTA beads three
times with 10 ml of buffer I plus 10% glycerol. Bound proteins were eluted by
incubation with an equal volume of buffer I containing 400 mM imidazole or with
23 gel sample buffer (4% sodium dodecyl sulfate [SDS], 0.2 M dithiothreitol,
20% glycerol).
In vitro association experiments. We harvested protein from FSY185 (wild-
type) cells. After breaking the cells in PME buffer with a French press, we
immediately added 300 to 500 ml of bacterial lysate containing recombinant
His6-Rbl2p and then proceeded as described above. The lysate was prepared
from E. coli cells containing pQE-60/RBL2 which had been induced with iso-
propyl-b-D-thiogalactopyranoside for 6 h. Approximately 2.5 ml of packed cells
were opened by sonication in 20 ml of buffer I, followed by centrifugation at
31,000 3 g for 20 min. To assay denatured proteins, we brought 1 ml of extract
to a final concentration of 6 M guanidine hydrochloride for 5 min at 0°C. We
diluted the sample (or untreated control) 100-fold into PME buffer plus protease
inhibitors plus 500 ml of recombinant His6-Rbl2p (;0.1 mg/ml), incubated the
mixture for 1 h at 4°C, and then isolated the complex as described for the in vivo
association experiments.
Dissociation experiments. We prepared His6-Rbl2p–b-tubulin complex from
JAY570 protein extracts, and His6–a/b-tubulin heterodimer from LTY333 pro-
tein extracts. Cells were opened in PME buffer by French press as described
above, and the extracts were centrifuged at 13,000 3 g and then mixed with
Ni-NTA slurries also as described above. Unbound proteins were washed away
by three washes (15 ml per 130 ml of resin), and we resuspended the samples in
PME buffer plus protease inhibitors (25-fold dilution). At various times, we
centrifuged aliquots of the samples, removed the supernatant, and eluted bound
proteins with buffer I containing 400 mM imidazole or with 23 gel sample buffer.
RESULTS
Characterization of a His6-Rbl2p–b-tubulin complex formed
in vivo. Previous work demonstrated that Rbl2p can form a
complex with b-tubulin but not a-tubulin in vivo, demonstrat-
ing the existence of a second pool of b-tubulin in the cell in
addition to that of the a/b-tubulin heterodimer (1). We orig-
inally isolated this complex by immunoprecipitation with anti-
b-tubulin or anti-Rbl2p antibodies. However, this isolation
method has drawbacks. First, the monoclonal anti-a-tubulin
antibody has only a modest level of affinity, so the immuno-
precipitates are somewhat unstable. Second, on SDS-polyacryl-
amide gels, the sizes of the tubulin polypeptides are similar to
those of the immunoglobulin G heavy chains, which are abun-
dant in the precipitate and interfere with analyses.
To avoid these problems in analyses of the Rbl2p–b-tubulin
complex, we constructed a version of the RBL2 gene encoding
a form of the protein with six histidines at its carboxy terminus.
By several criteria, this modified form of Rbl2p has the same
activities as does the unmodified form.
First, overexpressed His6-Rbl2p suppresses the lethality as-
sociated with overexpression of b-tubulin with an efficiency of
49%, under conditions where only 0.01% of cells containing
the YCpGAL control plasmid survive. This value is only slight-
ly less than the 70% efficiency achieved with unmodified Rbl2p
(1).
Second, like Rbl2p, His6-Rbl2p overexpression confers re-
sistance to the microtubule-depolymerizing drug benomyl.
Third, protein binding to His6-Rbl2p is similar to that of
unmodified Rbl2p. We mixed extracts of cells that inducibly
overexpress His6-Rbl2p with Ni-NTA beads (see Materials and
Methods). b-Tubulin binding to the beads strictly depended
upon His6-Rbl2p expression (Fig. 1). This complex, like the
one previously characterized by immunoprecipitation, contains
no detectable a-tubulin.
The level of Rbl2p–b-tubulin complex increases when both
of its components are co-overexpressed (data not shown), al-
though we detected no increase in Rbl2p levels when b-tubulin
alone was overexpressed. Analysis of extracts from the co-over-
expressing strains by gel filtration identified a peak containing
b-tubulin and Rbl2p which eluted at an apparent molecular
mass of ;60 kDa (3a), consistent with the finding by Melki and
colleagues that cofactor A and b-tubulin form a 1:1 hetero-
dimer (14). As shown in Fig. 2 below, we also detected this
complex in extracts of wild-type cells, but the level of the
complex was extremely low. To estimate the relative sizes of
the two pools, we used immunoprecipitation to measure the
proportion of the cellular b-tubulin not associated with a-tu-
bulin. The anti-a-tubulin antibody was covalently attached to
beads and was incubated with wild-type extract. Under condi-
tions where that antibody leaves ;1% of the total a-tubulin in
the supernatant, we found that ,2% of the b-tubulin also
remained. We can therefore place a limit on the proportion of
b-tubulin associated with Rbl2p as being no greater than 2% of
the total b-tubulin.
Ordering the formation of Rbl2p–b-tubulin complex and
a/b-tubulin heterodimer in vivo. To order the formation of
these two b-tubulin complexes with respect to one another, we
constructed yeast strains that would allow us to monitor the
compartmentalization of newly synthesized b-tubulin relative
to that of the steady-state pool. In FSY820 cells, the only
source of Rbl2p is a low-copy-number plasmid that constitu-
tively expresses His6-Rbl2p under the control of the RBL2
promoter. On the chromosome the constitutively expressed
b-tubulin gene is wild-type TUB2. An inducibly expressed b-tu-
bulin gene, tub2-590, is on a second plasmid under control of
the GAL promoter. The product of that gene, Tub2-590p, is a
fully functional b-tubulin protein. Because it lacks the carboxy-
terminal 12 amino acids, we could distinguish between the
FIG. 1. The His6-Rbl2p–b-tubulin complex formed in vivo is devoid of a-tu-
bulin. LTY292 cells carrying a plasmid-borne gene specifying His6-Rbl2p under
control of the GAL promoter were grown for 2 h in medium containing raffinose
(uninduced) or galactose (induced). The His6-Rbl2p was separated from extracts
by using Ni-NTA beads. The whole-cell extracts (W.C.E.) and bound proteins
were analyzed by immunoblotting for b-tubulin, a-tubulin, and Rbl2p as shown.
The bottom film was exposed six times longer than the top two. The presence of
b-tubulin in the bound proteins required expression of His6-Rbl2p, but no
a-tubulin was detected in the bound proteins under either condition.
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b-tubulin proteins by using two antibodies (206 and 339) that
bind specifically to the wild-type and truncated forms, respec-
tively (11). In addition, Tub2-590p migrates faster on SDS-
polyacrylamide gels than the wild-type Tub2p.
To examine the partitioning of newly synthesized b-tubulin,
a culture of FSY820 cells grown in raffinose was exposed to
galactose for 10 min and then to glucose for an additional 10
min. We fractionated extracts of these cells with anti-a-tubulin
antibodies to isolate the a/b-tubulin heterodimers and with
Ni-NTA beads to bind the His6-Rbl2p–b-tubulin complexes.
As a steady-state control, an identical culture of raffinose-
grown FSY820 cells was shifted to glucose for 20 min. The
distributions of the two b-tubulin proteins in whole-cell ex-
tracts and in the two fractions were assayed by SDS-polyacryl-
amide gel electrophoresis followed by immunoblotting.
Results from a representative experiment are shown in Fig.
2A. The different fractions are represented by very different
exposures because they are so different in abundance. Some
Tub2-590p, the induced b-tubulin protein, is detectable in the
steady-state cell extracts because the GAL promoter is weakly
expressed in raffinose medium.
To monitor the newly synthesized b-tubulin, we recovered
the fractions associated with a-tubulin and with Rbl2p and
normalized the recoveries using the constitutively expressed
Tub2p. Figure 2B presents an analysis of the results shown in
Fig. 2A. The short exposure to galactose increased the level of
Tub2-590p approximately fourfold, while the levels of wild-
type b-tubulin were unaffected. The ratio of Tub2-590p to
Tub2p associated with Rbl2p increased about 5.4-fold after the
induction. In contrast, the ratio for the two b-tubulin proteins
present as a/b-tubulin heterodimer increased only about 1.6-
fold.
This difference in partitioning of newly synthesized b-tubulin
is not the consequence of a subtle difference in the proper-
ties of the two proteins. We repeated this experiment using
FSY821 cells, in which the constitutive and inducible b-tubulin
genes are switched. In this experiment, the levels of the induc-
ible Tub2p increased sixfold after the same induction protocol.
After the induction, the relative proportion of this newly syn-
thesized b-tubulin protein to the constitutive Tub2-590p was
10-fold higher in the Rbl2p pool but only about 1.5-fold higher
in the a/b-tubulin heterodimer (data not shown).
These data demonstrate that newly synthesized b-tubulin
can bind to Rbl2p before it incorporates into a/b-tubulin. If
the opposite were true, i.e., if b-tubulin could bind to Rbl2p
only after it had been in heterodimer, we would not detect any
enrichment for the induced protein in the Rbl2p pool, since
the heterodimer pool is at least 50-fold larger than the Rbl2p
pool. It is important to note, however, that this result does not
demonstrate that this order is obligatory (see Discussion).
Formation of Rbl2p–b-tubulin in vitro. To determine if
Rbl2p could bind only to newly synthesized b-tubulin or if
instead it could bind to b-tubulin that had previously been in
a/b-tubulin heterodimers, we used an in vitro assay. We ex-
pressed His6-Rbl2p in E. coli and incubated it with extracts of
wild-type yeast cells and then assayed for bound proteins by
using Ni-NTA beads. We found that Rbl2p bound b-tubulin in
a time-dependent fashion (Fig. 3). Like the complex formed in
vivo, this in vitro complex contained only a trace amount of
a-tubulin, which amount did not increase with time. Therefore,
it is likely that the a-tubulin detected represents adventitious
binding.
The time course demonstrates a linear rate of association
between Rbl2p and b-tubulin for at least 4 h. Extrapolated
back to zero time, the kinetics give evidence for a small but
reproducible initial burst of complex formation. One interpre-
FIG. 2. Newly synthesized b-tubulin can bind to Rbl2p in vivo. Distribution of b-tubulin between the Rbl2p and a-tubulin pools in FSY 820 cells is shown. (A)
Immunoblots of whole-cell extracts (W.C.E.), anti-a-tubulin immunoprecipitates (I.P.), and proteins bound to His6-Rbl2p either at steady state (s.s.) or after a brief
(galactose for 10 min followed by glucose for 10 min) induction of Tub2-590p (pulse) are shown. The blots were probed with antibodies specific for either wild-type
Tub2p (206) or the faster-migrating Tub2-590p (339). Sample volumes and exposure times were adjusted to give detectable signals from all fractions. (B) Analysis of
the data shown in panel A. The ratios represent the proportions of the induced b-tubulin (Tub2-590p) relative to the constitutive b-tubulin (Tub2p) present as the
a/b-tubulin heterodimer or associated with Rbl2p from uninduced cells (steady state) and after a brief induction of Tub2-590p expression (pulse).
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tation of this biphasic time course is that it represents reaction
with two distinct in vitro pools of b-tubulin. The low rate at
which the majority of the complex forms may represent a
rate-determining release of free b-tubulin from the hetero-
dimer, by far the predominant population of tubulin in the
extract. The initial burst could represent the diffusion-con-
trolled reaction of a small equilibrium population of undimer-
ized b-tubulin in the yeast extracts, which should bind to Rbl2p
at the diffusion-controlled limit. The level of b-tubulin that
reacts at this high rate fits well with our estimate of the level of
b-tubulin not associated with a-tubulin in extracts (see above).
These results suggest that Rbl2p can interact with b-tubulin
molecules that have previously been dimerized and hence com-
pletely folded. Conversely, the ability of b-tubulin to bind to
Rbl2p in vitro is abolished by denaturation. We treated wild-
type yeast protein extracts with 6 M guanidine hydrochloride
and then diluted the protein into solutions containing His6-
Rbl2p. Conventional chaperone binding and folding assays
often make use of substrates that are denatured by treatment
with 6 M guanidine hydrochloride. Relative to the control
reaction mixtures that were diluted but not exposed to denaturing
agent, the amount of b-tubulin bound to Rbl2p was only barely
detectable (Fig. 4). In contrast, virtually no bound a-tubulin
was detected in either the denatured or untreated samples.
Immunoblots of these samples with anti-Rbl2p demonstrated
that the amounts of Rbl2p bound to beads were the same in
the treated and untreated samples. This result is consistent
with the failure of b-tubulin denatured in this fashion to bind
the murine Rbl2p homolog, cofactor A, in the in vitro system
(7, 8).
Stability of the Rbl2p–b-tubulin complex. The in vitro ex-
periment described above suggests that b-tubulin can transfer
from a-tubulin to Rbl2p. The in vivo experiment suggests that
b-tubulin can interact with Rbl2p before it interacts with a-tu-
bulin. A crucial issue for understanding Rbl2p function is how
these two complexes of b-tubulin compare to one another.
Accordingly, we measured their stabilities in vitro.
We isolated the His6-Rbl2p–b-tubulin complex from ex-
tracts of yeast cells that overproduce both proteins and then
measured the dissociation of the complex by monitoring the
loss of b-tubulin from the Ni-NTA beads (see Materials and
Methods). Under the conditions of this experiment, the His6-
Rbl2p protein does not dissociate from the beads. As shown in
Fig. 5, the Rbl2p–b-tubulin complex dissociates exponentially
through about two half-lives. These results are consistent with
a simple dissociation reaction with a half-life of about 2.5 h,
corresponding to a dissociation rate constant, koff, of 8 3 10
25
s21.
The stability of this complex should be compared to that of
the a/b-tubulin heterodimer with which it can interact. The
equilibrium dissociation constant for that heterodimer is re-
ported to be ;8 3 1027 M (4). We cannot measure the com-
parable constant for the Rbl2p–b-tubulin complex, either di-
rectly or indirectly (by measuring its association rate constant),
since we do not have a source of native monomeric b-tubulin.
However, the bimolecular association constants for molecules
of similar sizes are on the order of 107 to 108 M21 s21 (9). If
we choose the conservative value of 106 M21 s21, the Rbl2p–
b-tubulin complex would have a Kd of ;10
210. That value
would make the Rbl2p–b-tubulin complex significantly more
stable than the a/b-tubulin heterodimer. To compare the sta-
bilities of the complexes more directly by similar assays, we
prepared a/b-tubulin heterodimer from cells expressing His6-
Tub2p (see Materials and Methods). We isolated this complex
on Ni-NTA beads and then monitored its dissociation by as-
saying for loss of the a-tubulin polypeptide. The rate of a-tu-
bulin loss from the beads is low, consistent with a half-life for
the heterodimer of about 10 h (Fig. 5). Therefore, by using
essentially the same method to assay the stabilities of the two
complexes, it can be concluded that the a/b-tubulin hetero-
dimer dissociates much more slowly than does the Rbl2p–b-
tubulin complex.
DISCUSSION
That b-tubulin can interact specifically with a protein other
than a-tubulin suggests several possible functions for such a
complex. The results presented above characterize the forma-
tion and properties of the Rbl2p–b-tubulin complex.
The results demonstrate that the formation in vitro of the
Rbl2p–b-tubulin complex is dependent upon the conformation
of b-tubulin. Although there may be conformational alter-
ations of b-tubulin prior or subsequent to binding Rbl2p, the
form of b-tubulin that binds Rbl2p is at least in equilibrium
FIG. 3. Formation of His6-Rbl2p–b-tubulin complex in vitro. Bacterial ex-
tract containing His6-Rbl2p was incubated with wild-type yeast cell extracts at
4°C. At various times, an aliquot was removed and added to Ni-NTA beads for
15 min. The beads were washed, and the bound proteins were assayed by elution
followed by immunoblotting with anti-tubulin antibodies. The data are reported
as percent b-tubulin and a-tubulin bound as a function of time.
FIG. 4. Rbl2p does not bind to denatured b-tubulin. Extracts from wild-type
cells (W.C.E.) were incubated either with control buffer (2) or with 6 M gua-
nidine hydrochloride (1) for 5 min, diluted 100-fold, and then incubated with
His6-Rbl2p plus Ni-NTA beads. The specifically bound proteins were eluted
from the beads and assayed for the presence of both b-tubulin and a-tubulin by
immunoblotting. The binding of b-tubulin to Rbl2p was essentially abolished by
the preincubation with denaturing agent. No bound a-tubulin was detected
under either condition.
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with the form that binds a-tubulin. That both the in vivo and in
vitro complexes are essentially devoid of a-tubulin argues that
Rbl2p competes with a-tubulin for binding to b-tubulin, per-
haps because both ligands bind to similar sites on b-tubulin.
These characteristics of the Rbl2p–b-tubulin complex are con-
sistent with the comparable efficiencies of Rbl2p and a-tubulin
in rescuing cells from b-tubulin lethality. In cell extracts, it is
clear that much more b-tubulin is associated with a-tubulin
than with Rbl2p, reflecting not only relative stabilities but also
the likelihood that there is much less Rbl2p than a-tubulin in
wild-type cells. We note that the overproduction of Rbl2p is
modestly toxic (1), a phenotype that may be explained by the
ability of high levels to compete successfully with a-tubulin and
so to sequester b-tubulin.
Two results are consistent with a role for Rbl2p in the
pathway leading to heterodimer formation. First, the in vitro
data suggest that the a/b-tubulin heterodimer is more stable
than the Rbl2p–b-tubulin complex. Of course this comparison
is of dissociation rates that need not reflect conditions in vivo.
For example, that the tubulin heterodimer can have an alter-
native fate to dissociation, i.e., polymerization, may affect its
apparent stability in the cytoplasm. In addition, there may be
effectors that modify the stability of either b-tubulin complex.
Second, the pulse induction experiment shows that b-tubulin
can interact with Rbl2p before it interacts with a-tubulin. This
result is consistent with the interactions in vitro reported for
the refolding of completely denatured b-tubulin (21), which
suggest that the murine homolog of Rbl2p, cofactor A, binds
b-tubulin shortly after its release from the Tcp-1 complex.
However, at steady state the amount of a-tubulin available for
dimerization with the newly synthesized material may be lim-
iting. Under that circumstance, the induced b-tubulin may be
forced into association with uncomplexed Rbl2p. Therefore,
this experiment does not permit us to conclude that this se-
quence of formation of the two b-tubulin complexes is oblig-
atory or that b-tubulin ordinarily passes through the Rbl2p
complex as part of dimer formation. The experiment does
establish that Rbl2p may be on the pathway of heterodimer
formation for newly synthesized b-tubulin.
These results do encourage further comparisons with the in
vitro assay for Rbl2p/cofactor A in heterodimer formation. We
show here that Rbl2p can bind to b-tubulin that has been in the
a/b-tubulin heterodimer. In contrast, Gao et al. originally re-
ported that b-tubulin bound to cofactor A fails to exchange
into exogenous heterodimer in the in vitro reaction (7). That
result could mean that the formation of Rbl2p–b-tubulin from
tubulin heterodimer is not reversible. Alternatively, the inabil-
ity to detect this exchange reaction may reflect the slow disso-
ciation of b-tubulin from the Rbl2p complex relative to the
length of the in vitro assay. It may also reflect the fact that the
level of a-tubulin available to bind the released b-tubulin in
that assay may be very low, limited by the rate of dissociation
from the heterodimer.
What might Rbl2p do in cells? We can consider here two
possible roles. First, the demonstration that Rbl2p–b-tubulin
can form from newly synthesized protein, before that b-tubulin
is incorporated into heterodimer, demonstrates that Rbl2p
may participate as a scaffolding protein for b-tubulin in the
assembly of the tubulin heterodimer. If so, it obviously does
not define the sole pathway for formation of this essential
protein, since RBL2 is itself not essential in wild-type cells.
Alternatively, Rbl2p could serve as a buffer to sequester free
b-tubulin. Even modest excesses of b-tubulin are deleterious to
the cell. For example, strains deleted for the TUB3 gene, and
so lacking about 15% of their normal a-tubulin complement,
show distinct microtubule phenotypes (17), which are com-
pletely suppressed by an extra copy of RBL2 under control of
its own promoter (1). Experimentally, the extreme toxicity of
b-tubulin is best remedied by two proteins that bind to it
specifically, a-tubulin and Rbl2p. The cell could find an advan-
tage in using Rbl2p rather than excess a-tubulin in this role.
Increased levels of a-tubulin would have the consequence of
changing the level of heterodimer, which in turn could affect
the balanced dynamics likely to be an important part of suc-
cessful microtubule function.
In some genetic backgrounds, including those carrying mu-
tations in a-tubulin genes, RBL2 function is essential (1). De-
tailed analysis of these situations may provide more insight
both into Rbl2p function and into cellular mechanisms for
regulating tubulin assembly.
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